IPO

Vijaya Diagnostic Centre Limited IPO

Mainboard

Hospital & Healthcare Services

Listed On: Sep 14, 2021 at ₹ 540.0 (NSE)

₹ 14868 /28 Shares

Check Allotment

01 Sep, 2021

Open Date

03 Sep, 2021

Close Date

09 Sep, 2021

Allotment Date

14 Sep, 2021

Listing Date
Price Summary

Last Closing

994.75 (87.34%)

52 Week High

1,275.00

52 Week Low

740.00

Last Update

19-Dec-2025 3:30 PM
IPO Issue Details
  • Issue Price ₹522-531 per equity share (Employee Discount - ₹52)
  • Face Value ₹1 Per Equity Share 
  • Issue Price 35,688,064 Eq Shares of ₹1 (aggregating up to ₹1,895.04 Cr)

    #Offer for Sale: 35,688,064 Eq Shares of ₹1 (aggregating up to ₹1,895.04 Cr)
  • Listing at BSE, NSE
  • List Price 540.0 (NSE)
  • Listing Date 2021-09-14
  • Lead Manager Edelweiss Financial Services Ltd, ICICI Securities Limited, Kotak Mahindra Capital Company Limited
  • Registrar KFintech Private Limited
IPO Details
  • Retail Portion 35%
IPO Documents
IPO Details


The IPO of is priced at ₹522-531 per equity share, which has a face value of ₹1 Per Equity Share  each, IPO bidding starts from Sep 1, 2021 and ends on Sep 3, 2021. The allotment for IPO will be finalized on Sep 9, 2021. IPO will be listed on BSE, NSE, with a tentative listing date fixed as Sep 14, 2021. The company shall list its equity shares on the BSE, NSE. KFintech Private Limited is the registrar of the issue.

The book-running lead manager for the IPO is/are Edelweiss Financial Services Ltd, ICICI Securities Limited, Kotak Mahindra Capital Company Limited.


The IPO sets its price band at 522-531 for each share. A single application for Vijaya Diagnostic Centre Limited IPO must contain at least 28 shares.

Read More
IPO Subscription Analysis And Details
Retail
1.10x
QIB
13.07x
NII
1.33x
Total
4.54x
As on QIB NII Retail Employee Total
Shares Offered / Reserved 71,07,613 53,30,710 1,24,38,323 1,50,000 2,50,26,646
Day 1 01-09-21 05:00 PM
0.23 x 0.01 0.46 x 0.25 x 0.30 x
Day 2 02-09-21 05:00 PM
0.32 x 0.05 0.74 x 0.52 x 0.48 x
Day 3 03-09-21 05:00 PM
13.07 x 1.33 1.10 x 0.98 x 4.54 x
Valuations
Earnings Per Share (EPS) ₹8.33/-
P/E Ratio 63.78
RoNW 23.14%
Net Asset Value (NAV) - As on 30.06.21 ₹38.53
Company Financials
In Crs.
In Cr.
31-Mar-21 31-Mar-20 31-Mar-19
Assets 540.94 482.25 406.43
Revenue 388.59 354.18 302.94
Profit After Tax 84.91 62.50 46.27
About Company

Vijaya Diagnostic Centre is one of the fastest-growing diagnostic chains in Southern India. The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers.

Company's operational network consists of 80 diagnostic centers and 11 reference laboratories spread across 13 cities and towns in the states of Telangana, Andhra Pradesh, National Capital Region, and Kolkata. 96.2% of the revenue comes from Hyderabad, the rest of Telangana, and the Andhra Pradesh region. During the year ended March 31, 2021, the company conducted approximately 6.20 Mn pathology tests and 0.89 Mn radiology tests for approximately 2.63 Mn customers.

As of March 31, 2021, all Vijaya Diagnostic Centre laboratories hold National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditations, and three diagnostic centers hold Patient Safety & Quality of Care (NABH) accreditations.

Read More
- Promoter(s)

Dr. S. Surendranath Reddy

Pre Issue Share Holding : 59.78%

Post Issue Share Holding : 54.78%

IPO - Issue Objectives
1

Achieve the benefits of share listing on the Stock Exchanges.

2

To make an offer for sale (OFS) of 35,688,064 shares.

IPO - Anchor Investors

Vijaya Diagnostic Centre mobilises Rs 566.12 crore from anchor investors ahead of IPO

Marquee investors participated in anchor book included Government Pension Fund Global, Fidelity Investment Trust, Aberdeen, Abu Dhabi Investment Authority (ADIA), Kuwait Investment Authority (KIA), Pioneer Investment Fund, CLSA, Franklin Templeton MF, Bajaj Allianz Life Insurance, SBI Life Insurance, and Kotak Life Insurance.

Among domestic investors, SBI Mutual Fund, Axis Mutual Fund, Aditya Birla Mutual Fund, ICICI Prudential Mutual Fund, Nippon India Mutual Fund, Franklin Templeton Mutual Fund, Mirae Mutual Fund, Edelweiss MF and DSP Mutual Fund.

IPO - Peers Comparison
P/B Ratio P/E Ratio RoNW Revenue(in Cr.)
Vijaya Diagnostic Centre Limited 13.78 63.78 23.14% 388.59
Dr. Lal Pathlabs Limited 26.16 85.03 30.78% 1,632.60
Metropolis Healthcare Ltd 19.65 54.64 35.95% 1,010.03
Thyrocare Technologies Ltd 14.81 40.29 36.76% 507.05